Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 4/2012

01-07-2012 | Original Article

The influence of follistatin on mechanical properties of bone tissue in growing mice with overexpression of follistatin

Authors: Anna Gajos-Michniewicz, Elzbieta Pawlowska, Tomasz Ochedalski, Agnieszka Piastowska-Ciesielska

Published in: Journal of Bone and Mineral Metabolism | Issue 4/2012

Login to get access

Abstract

Mechanical competence of bones is mainly associated with tissue quality that depends on proper bone metabolism processes. An imbalance in the regulation of bone metabolism leads to pathological changes in bone tissue leading to susceptibility to bone fractures and bone deterioration processes. Bone metabolism is regulated to a large extent by the members of the transforming growth factor-β superfamily, i.e., activins and bone morphogenetic proteins. However, their function is regulated by a single-chain protein called follistatin (FS). The aim of this study was to test the hypothesis that overexpression of FS in growing mice results in impairments in bone morphology and mechanical properties. Moreover, we wanted to investigate how geometrical, structural and material properties of bone tissue change with age. The experiment was performed on growing C57BL/6 TgNK14-mFst/6J mice, overexpressing FS (F mice) versus C57BL/6J mice used as controls (C mice). To establish how overexpression of FS influences bone tissue quality, we studied mice femurs to determine geometrical, structural and material properties of the skeleton. To determine mechanical resistance of bone tissue, femurs were loaded to failure in a three-point bending test. Obtained results indicated that overexpression of FS negatively influences bone metabolism. It was found that mutation results with a significant decrease of all measured biomechanical strength variables in F mice in comparison to C mice. Overexpression of FS leads to decreased quality of skeleton, increasing susceptibility to bone fractures.
Literature
1.
go back to reference Bilezikjian LM, Leal AM, Blount AL, Corrigan AZ, Turnbull AV, Vale WW (2003) Rat anterior pituitary folliculostellate cells are target of interleukin-1β and major source of intrapituitary follistatin. Endocrinology 144:732–740PubMedCrossRef Bilezikjian LM, Leal AM, Blount AL, Corrigan AZ, Turnbull AV, Vale WW (2003) Rat anterior pituitary folliculostellate cells are target of interleukin-1β and major source of intrapituitary follistatin. Endocrinology 144:732–740PubMedCrossRef
2.
go back to reference Bonadio J, Jepsen KJ, Mansoura MK, Jaenisch R, Kuhn JL, Goldstein SA (1993) A murine skeletal adaptation that significantly increases cortical bone mechanical properties. J Clin Invest 92:1697–1705PubMedCrossRef Bonadio J, Jepsen KJ, Mansoura MK, Jaenisch R, Kuhn JL, Goldstein SA (1993) A murine skeletal adaptation that significantly increases cortical bone mechanical properties. J Clin Invest 92:1697–1705PubMedCrossRef
3.
go back to reference Brodt MD, Ellis CB, Silva MJ (1999) Growing C57B1/6 mice increase whole bone mechanical properties by increasing geometric and material properties. J Bone Miner Res 14:2159–2166PubMedCrossRef Brodt MD, Ellis CB, Silva MJ (1999) Growing C57B1/6 mice increase whole bone mechanical properties by increasing geometric and material properties. J Bone Miner Res 14:2159–2166PubMedCrossRef
4.
go back to reference Davison KS, Siminoski K, Adachi JD, Hanley DA, Goltzman D, Hodsman AB, Josse R, Kaiser S, Olszynski WP, Papaioannou A, Ste-Marie LG, Kendler DL, Tenenhouse A, Brown JP (2006) Bone strength: the whole is greater than the sum of its parts. Semin Arthritis Rheum 36:22–31PubMedCrossRef Davison KS, Siminoski K, Adachi JD, Hanley DA, Goltzman D, Hodsman AB, Josse R, Kaiser S, Olszynski WP, Papaioannou A, Ste-Marie LG, Kendler DL, Tenenhouse A, Brown JP (2006) Bone strength: the whole is greater than the sum of its parts. Semin Arthritis Rheum 36:22–31PubMedCrossRef
5.
go back to reference Eijken M, Swagemakers S, Koedam M, Steenbergen C, Derkx P, Uitterlinden AG, van der Spek PJ, Visser JA, de Jongm FH, Pols HAP, van Leeuwen JP (2007) The activin A–follistatin system: potent regulator of human extracellular matrix mineralization. FASEB J 21:1–12CrossRef Eijken M, Swagemakers S, Koedam M, Steenbergen C, Derkx P, Uitterlinden AG, van der Spek PJ, Visser JA, de Jongm FH, Pols HAP, van Leeuwen JP (2007) The activin A–follistatin system: potent regulator of human extracellular matrix mineralization. FASEB J 21:1–12CrossRef
6.
go back to reference Ferretti JC, Capozza RF, Mondelo N, Zanchetta JR (1993) Interrelationships between densitometric, geometric and mechanical properties of rat femora: increases concerning mechanical regulation of bone modeling. J Bone Miner Res 8:1389–1395PubMedCrossRef Ferretti JC, Capozza RF, Mondelo N, Zanchetta JR (1993) Interrelationships between densitometric, geometric and mechanical properties of rat femora: increases concerning mechanical regulation of bone modeling. J Bone Miner Res 8:1389–1395PubMedCrossRef
7.
go back to reference Funaba M, Ogawa K, Murata T, Fujimura H, Murata E, Abe M, Takahashi M, Torii K (1996) Follistatin and activin in bone: expression and localization during endochondral bone development. Endocrinology 137:4250–4258PubMedCrossRef Funaba M, Ogawa K, Murata T, Fujimura H, Murata E, Abe M, Takahashi M, Torii K (1996) Follistatin and activin in bone: expression and localization during endochondral bone development. Endocrinology 137:4250–4258PubMedCrossRef
8.
go back to reference Isaksson H, Harjula T, Koistinen A, Ivarinen J, Seppänen K, Arokoski JPA, Brama PA, Jurvelin JS, Helminen HJ (2010) Collagen and mineral deposition of rabbit cortical bone during maturation and growth: effects on tissue properties. J Orthop Res 28:1626–1633PubMedCrossRef Isaksson H, Harjula T, Koistinen A, Ivarinen J, Seppänen K, Arokoski JPA, Brama PA, Jurvelin JS, Helminen HJ (2010) Collagen and mineral deposition of rabbit cortical bone during maturation and growth: effects on tissue properties. J Orthop Res 28:1626–1633PubMedCrossRef
9.
go back to reference Jämsä T, Jalovaara P, Peng Z, Väänänen HK, Tuukkanen J (1998) Comparison of three-point bending test and peripheral quantitative computer tomography analysis in the evaluation of the strength of mouse femur and tibia. Bone 23:155–161PubMedCrossRef Jämsä T, Jalovaara P, Peng Z, Väänänen HK, Tuukkanen J (1998) Comparison of three-point bending test and peripheral quantitative computer tomography analysis in the evaluation of the strength of mouse femur and tibia. Bone 23:155–161PubMedCrossRef
10.
go back to reference Kochanowska I, Chaberek S, Wojtowicz A, Marczyński B, Włodarski K, Dytko M, Ostrowski K (2007) Expression of genes for bone morphogenetic proteins BMP-2, BMP-4 and BMP-6 in various parts of the human skeleton. BMC Musculoskelet Disord 8:1–10CrossRef Kochanowska I, Chaberek S, Wojtowicz A, Marczyński B, Włodarski K, Dytko M, Ostrowski K (2007) Expression of genes for bone morphogenetic proteins BMP-2, BMP-4 and BMP-6 in various parts of the human skeleton. BMC Musculoskelet Disord 8:1–10CrossRef
11.
go back to reference Kumar TR (2005) Too many follistatins: racing inside and getting out of the cell. Endocrinology 146:5048–5051PubMedCrossRef Kumar TR (2005) Too many follistatins: racing inside and getting out of the cell. Endocrinology 146:5048–5051PubMedCrossRef
12.
go back to reference Lin S, Morrison J, Phillips D, Kretser D (2003) Regulation of ovarian function by the TGF-β superfamily and follistatin. Reproduction 126:133–148PubMedCrossRef Lin S, Morrison J, Phillips D, Kretser D (2003) Regulation of ovarian function by the TGF-β superfamily and follistatin. Reproduction 126:133–148PubMedCrossRef
14.
go back to reference Phillips DJ, Kretser DM (1998) Follistatin: a multifunctional regulatory protein. Front Neuroendocrinol 19:287–322PubMedCrossRef Phillips DJ, Kretser DM (1998) Follistatin: a multifunctional regulatory protein. Front Neuroendocrinol 19:287–322PubMedCrossRef
15.
go back to reference Piastowska-Ciesielska AW, Gralak MA (2010) Influence of a low dose of dietary soybean on bone properties and mineral status in young rats. BioFactors 36:451–458PubMedCrossRef Piastowska-Ciesielska AW, Gralak MA (2010) Influence of a low dose of dietary soybean on bone properties and mineral status in young rats. BioFactors 36:451–458PubMedCrossRef
16.
go back to reference Risbridger GP, Mellor SL, McPherson SJ, Schmitt JF (2001) The contribution of inhibins and activins to malignant prostate disease. Mol Cell Endocrinol 180:149–153PubMedCrossRef Risbridger GP, Mellor SL, McPherson SJ, Schmitt JF (2001) The contribution of inhibins and activins to malignant prostate disease. Mol Cell Endocrinol 180:149–153PubMedCrossRef
17.
go back to reference Saffar KPA, Rajaai NS (2009) How does the bone shaft geometry affect its bending properties. Am J Appl Sci 6:463–470CrossRef Saffar KPA, Rajaai NS (2009) How does the bone shaft geometry affect its bending properties. Am J Appl Sci 6:463–470CrossRef
18.
go back to reference Schriefer JL, Robling AG, Warden SJ, Fournier AJ, Mason JJ, Turner CH (2005) A comparison of mechanical properties derived from multiple skeletal sites in mice. J Biomech 38:467–475PubMedCrossRef Schriefer JL, Robling AG, Warden SJ, Fournier AJ, Mason JJ, Turner CH (2005) A comparison of mechanical properties derived from multiple skeletal sites in mice. J Biomech 38:467–475PubMedCrossRef
19.
go back to reference Schneyer AL, Wang Q, Sidis Y, Sluss PM (2004) Differential distribution of follistatin isoforms: application of a new FS315- specific immunoassay. J Clin Endocrinol Metab 89:5067–5075PubMedCrossRef Schneyer AL, Wang Q, Sidis Y, Sluss PM (2004) Differential distribution of follistatin isoforms: application of a new FS315- specific immunoassay. J Clin Endocrinol Metab 89:5067–5075PubMedCrossRef
20.
go back to reference Tardif G, Hum D, Pelletier JP, Boileau C, Ranger P, Martel-Pelleter J (2004) Differential gene expression and regulation of the bone morphogenetic protein antagonist follistatin and gremlin in normal and osteoartritic chondrocytes and synovial fibroblasts. Arthritis Rheum 50:2521–2530PubMedCrossRef Tardif G, Hum D, Pelletier JP, Boileau C, Ranger P, Martel-Pelleter J (2004) Differential gene expression and regulation of the bone morphogenetic protein antagonist follistatin and gremlin in normal and osteoartritic chondrocytes and synovial fibroblasts. Arthritis Rheum 50:2521–2530PubMedCrossRef
21.
go back to reference Venken K, Callewaert F, Boonen S, Vanderschueren D (2008) Sex hormones, their receptors and bone health. Osteoporos Int 19:1517–1525PubMedCrossRef Venken K, Callewaert F, Boonen S, Vanderschueren D (2008) Sex hormones, their receptors and bone health. Osteoporos Int 19:1517–1525PubMedCrossRef
22.
go back to reference Vukicevic S, Sampath K (2004) Bone morphogenetic proteins: regeneration of bone and beyond. Birkhäuser, BasalCrossRef Vukicevic S, Sampath K (2004) Bone morphogenetic proteins: regeneration of bone and beyond. Birkhäuser, BasalCrossRef
23.
go back to reference Wan M, Cao X (2005) BMP signaling in skeletal development. Biochem Biophys Res Commun 328:651–657PubMedCrossRef Wan M, Cao X (2005) BMP signaling in skeletal development. Biochem Biophys Res Commun 328:651–657PubMedCrossRef
24.
go back to reference Wankell M, Munz B, Hübner G, Hans W, Wolf E, Goppelt A, Werner S (2001) Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis. EMBO J 20:5361–5372PubMedCrossRef Wankell M, Munz B, Hübner G, Hans W, Wolf E, Goppelt A, Werner S (2001) Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis. EMBO J 20:5361–5372PubMedCrossRef
25.
go back to reference Xiao YT, Xiang LX, Shao JZ (2007) Bone morphogenetic protein. Biochem Biophys Res Commun 362:550–553PubMedCrossRef Xiao YT, Xiang LX, Shao JZ (2007) Bone morphogenetic protein. Biochem Biophys Res Commun 362:550–553PubMedCrossRef
Metadata
Title
The influence of follistatin on mechanical properties of bone tissue in growing mice with overexpression of follistatin
Authors
Anna Gajos-Michniewicz
Elzbieta Pawlowska
Tomasz Ochedalski
Agnieszka Piastowska-Ciesielska
Publication date
01-07-2012
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 4/2012
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-011-0347-8

Other articles of this Issue 4/2012

Journal of Bone and Mineral Metabolism 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine